Issues Encountered When Modelling The Long Term Clinical Effectiveness Of Treatments From Short Term Trials Using Second-Line Treatments For Advanced Or Metastatic Renal Cell Carcinoma (AMRCC) As An Example

Autor:	C Karner, M Bacelar, F Salih, K. Kew, Steven J Edwards, P. Cain, Natalie Masento, Victoria Wakefield
Rok vydání:	2017
Předmět:	Oncology medicine.medical_specialty Clinical effectiveness business.industry Health Policy Public Health Environmental and Occupational Health medicine.disease Term (time) Surgery Second line Renal cell carcinoma Internal medicine medicine business
Zdroj:	Value in Health. 20:A752
ISSN:	1098-3015
DOI:	10.1016/j.jval.2017.08.2105
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9059f53c81d81c2ea74e66f937bb76ae https://doi.org/10.1016/j.jval.2017.08.2105 Zobrazit plný text záznamu Full Text from ScienceDirect